Giant Biogene Holding Co., Ltd. (2367.HK)
- Previous Close
84.550 - Open
84.600 - Bid 84.650 x --
- Ask 84.700 x --
- Day's Range
82.750 - 85.000 - 52 Week Range
35.000 - 85.350 - Volume
3,785,471 - Avg. Volume
6,075,713 - Market Cap (intraday)
86.906B - Beta (5Y Monthly) 0.84
- PE Ratio (TTM)
38.07 - EPS (TTM)
2.230 - Earnings Date Mar 26, 2025
- Forward Dividend & Yield 0.65 (0.76%)
- Ex-Dividend Date Jun 17, 2025
- 1y Target Est
86.12
Giant Biogene Holding Co., Ltd., an investment holding company, designs, develops, and manufactures skin treatment products with recombinant collagen in the People's Republic of China. It also develops and manufactures rare ginsenosides technology-based functional food products; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional food products primarily under the Comfy, Collgene, Ke Yu, and SKIGIN brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'an, the People's Republic of China.
www.xajuzi.com1,758
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 2367.HK
View MorePerformance Overview: 2367.HK
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2367.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2367.HK
View MoreValuation Measures
Market Cap
86.91B
Enterprise Value
80.57B
Trailing P/E
38.06
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
14.18
Price/Book (mrq)
11.29
Enterprise Value/Revenue
13.43
Enterprise Value/EBITDA
29.67
Financial Highlights
Profitability and Income Statement
Profit Margin
37.23%
Return on Assets (ttm)
21.92%
Return on Equity (ttm)
35.88%
Revenue (ttm)
5.54B
Net Income Avi to Common (ttm)
2.06B
Diluted EPS (ttm)
2.230
Balance Sheet and Cash Flow
Total Cash (mrq)
5.88B
Total Debt/Equity (mrq)
0.09%
Levered Free Cash Flow (ttm)
1.44B